Effect of MDI Actuation Timing on Inhalation Dosimetry in a Human Respiratory Tract Model

Mohamed Talaat; Xiuhua Si; Jinxiang Xi

doi:10.3390/ph15010061

Effect of MDI Actuation Timing on Inhalation Dosimetry in a Human Respiratory Tract Model

Pharmaceuticals (Basel). 2022 Jan 4;15(1):61. doi: 10.3390/ph15010061.

Authors

Mohamed Talaat¹, Xiuhua Si², Jinxiang Xi¹

Affiliations

¹ Department of Biomedical Engineering, University of Massachusetts, Lowell, MA 01854, USA.
² Department of Aerospace, Industrial, and Mechanical Engineering, California Baptist University, Riverside, CA 92504, USA.

Abstract

Accurate knowledge of the delivery of locally acting drug products, such as metered-dose inhaler (MDI) formulations, to large and small airways is essential to develop reliable in vitro/in vivo correlations (IVIVCs). However, challenges exist in modeling MDI delivery, due to the highly transient multiscale spray formation, the large variability in actuation-inhalation coordination, and the complex lung networks. The objective of this study was to develop/validate a computational MDI-releasing-delivery model and to evaluate the device actuation effects on the dose distribution with the newly developed model. An integrated MDI-mouth-lung (G9) geometry was developed. An albuterol MDI with the chlorofluorocarbon propellant was simulated with polydisperse aerosol size distribution measured by laser light scatter and aerosol discharge velocity derived from measurements taken while using a phase Doppler anemometry. The highly transient, multiscale airflow and droplet dynamics were simulated by using large eddy simulation (LES) and Lagrangian tracking with sufficiently fine computation mesh. A high-speed camera imaging of the MDI plume formation was conducted and compared with LES predictions. The aerosol discharge velocity at the MDI orifice was reversely determined to be 40 m/s based on the phase Doppler anemometry (PDA) measurements at two different locations from the mouthpiece. The LES-predicted instantaneous vortex structures and corresponding spray clouds resembled each other. There are three phases of the MDI plume evolution (discharging, dispersion, and dispensing), each with distinct features regardless of the actuation time. Good agreement was achieved between the predicted and measured doses in both the device, mouth-throat, and lung. Concerning the device-patient coordination, delayed MDI actuation increased drug deposition in the mouth and reduced drug delivery to the lung. Firing MDI before inhalation was found to increase drug loss in the device; however, it also reduced mouth-throat loss and increased lung doses in both the central and peripheral regions.

Keywords: actuation–inhalation coordination; dispersion; high-speed imaging; metered dose inhaler (MDI); orifice; polydisperse distribution; press-and-breathe.